AV
Atypical Ventures
Activity from announced rounds
Activity in this selectionOct 17, 2026 · Sep 18, 2026
Atypical Ventures is Christopher Wake’s investment firm, associated with frontier-technology investing.
Recorded funding activity
Its recorded financings include Shennon Biotechnologies’ precision T-cell engagers for solid tumors, PhoenixAI’s analytical database for agents querying enterprise data, and Ventaris Surgical’s ureteroscopic system for kidney-stone clearance. The companies’ own announcements identify Atypical Ventures across these different technologies.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.